Skip to main content

neonatal abstinence syndrome Archives

Benzodiazepine use with opioids intensifies neonatal abstinence syndrome

Jul. 1, 2019—Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.

Read more


Long-term unemployment linked to increase in babies born with drug withdrawal

Jan. 29, 2019—Babies born after being exposed to opioids before birth are more likely to be delivered in regions of the U.S. with high rates of long-term unemployment and lower levels of mental health services, according to a study from researchers at Vanderbilt University Medical Center and the RAND Corporation.

Read more


Team Hope program’s mission is to enhance care for newborns with NAS

Jul. 26, 2018—A collaborative program across units at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt is changing the way nurses and doctors care for newborns diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS).

Read more


First lady visits Children’s Hospital to learn about VUMC’s opioid approach

Jul. 26, 2018—First lady Melania Trump visited Monroe Carell Jr. Children’s Hospital at Vanderbilt Tuesday to learn firsthand about Team Hope, Vanderbilt’s multidisciplinary team focused on helping infants born with neonatal abstinence syndrome (NAS) as well as their families.

Read more


Opioid epidemic focus of June 27 Student-Invited Pharmacology Forum

Jun. 14, 2018—“America’s Opioid Epidemic” is the theme of the 27th annual Joel G. Hardman Student-Invited Pharmacology Forum, beginning at 9 a.m. Wednesday, June 27, in the Vanderbilt Student Life Center.

Read more


Early discharge of NAS infants prolongs treatment

May. 17, 2018—Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study.

Read more


Study tracks impact of NAS on state Medicaid programs 

Mar. 23, 2018—In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.

Read more


Discussing the opioid crises

Feb. 15, 2018—Stephen Patrick, MD, MPH, MS, assistant professor of Pediatrics and Health Policy in the Division of Neonatology at Monroe Carell Jr. Children’s Hospital at Vanderbilt, testified before Congress recently about the rise and impact of drug withdrawal symptoms in newborns, also known as neonatal abstinence syndrome (NAS).

Read more


Patrick honored for neonatal abstinence syndrome research

Jun. 15, 2017—Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero.

Read more


Study finds male infants at increased risk for NAS

May. 4, 2017—Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics.

Read more


American Academy of Pediatrics, Vanderbilt neonatologist urge public health approach for women who use opioids during pregnancy

Feb. 20, 2017—Punitive approach has not been shown to be effective and may deter women from seeking help The American Academy of Pediatrics (AAP) issued a statement today stating that a public health response, rather than a punitive approach, is needed to address the increasing number of pregnant women using opioids. Vanderbilt neonatologist Stephen Patrick, M.D., co-authored...

Read more


Standardizing care improves outcomes for infants born with neonatal abstinence syndrome

Apr. 15, 2016—Standardizing hospital care policies across institutions for infants diagnosed with drug withdrawal symptoms at birth reduces their length of treatment and hospitalization, according to new research led by Vermont Oxford Network, Vanderbilt and the University of Michigan Health System.

Read more


Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more